We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approval For Phase I Trial of Gene-Edited Leukemia Therapeutic

News   Feb 20, 2017

 
FDA Approval For Phase I Trial of Gene-Edited Leukemia Therapeutic
 
 
 

RELATED ARTICLES

First Patient in the UK Receives Pioneering Form of Radiotherapy

News

The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, have delivered the first ever treatment in the UK using a Magnetic Resonance Linear Accelerator (MR Linac) machine.

READ MORE

Tumor Cell Metastasis Challenges Laws of Physics

News

A new study reveals the forces malignant tumor cells use to spread. The relation between these forces and the cell movement goes beyond current physical laws.

READ MORE

Harnessing AI to Improve Drug Combination Design

News

Artificial intelligence is having a positive impact on drug development and personalized medicine. With the ability to efficiently analyze small datasets that focus on the specific disease of interest, small dataset-based AI platforms can rationally design optimal drug combinations that are effective and based on real experimental data and not mechanistic assumptions or predictive modeling.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE